KeyBanc Upgrades Summit Hotel Properties (INN) to Buy; Valuation Looks Good Again
Get Alerts INN Hot Sheet
Price: $6.14 -0.32%
Rating Summary:
7 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
7 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
KeyBanc upgraded Summit Hotel Properties (NYSE: INN) to Buy with a price target of $9.00.
KeyBanc analyst says, "We are raising our investment rating on Summit Hotel Properties as we believe the recent market downturn has created a compelling buying opportunity. We lowered our opinion from a BUY to a HOLD on August 8 at $10.65 and since then the shares are off 37% (S&P 500 is up 2% over that same time frame) and the shares currently sport a 6.7% dividend yield. Additionally, INN trades at the lowest EV/Key in our lodging REIT coverage universe at $67,000 per key vs. the group average of $172,000 per key. "
For more ratings news on Summit Hotel Properties click here and for the rating history of Summit Hotel Properties click here.
Shares of Summit Hotel Properties closed at $6.70 yesterday.
KeyBanc analyst says, "We are raising our investment rating on Summit Hotel Properties as we believe the recent market downturn has created a compelling buying opportunity. We lowered our opinion from a BUY to a HOLD on August 8 at $10.65 and since then the shares are off 37% (S&P 500 is up 2% over that same time frame) and the shares currently sport a 6.7% dividend yield. Additionally, INN trades at the lowest EV/Key in our lodging REIT coverage universe at $67,000 per key vs. the group average of $172,000 per key. "
For more ratings news on Summit Hotel Properties click here and for the rating history of Summit Hotel Properties click here.
Shares of Summit Hotel Properties closed at $6.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- Wolfe Research Upgrades Janux Therapeutics (JANX) to Outperform, 'An ARM Out of the Penalty Box'
- JPMorgan Upgrades East Japan Railway Co (9020:JP) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
KeyBanc, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share